Volume 22, Issue 3, 2022
Reduced Immunogenicity of Intraparenchymal Delivery of Adeno-Associated Virus Serotype 2 Vectors: Brief Overview
Pp: 185-190
Author(s): Wuh-Liang Hwu, Shin-Ichi Muramatsu* and Bruria Gidoni-Ben-Zeev
DOI: 10.2174/1566523221666210922155413
Published on: 22 September, 2021
Clinical Development of Cell Therapies to Halt Lysosomal Storage Diseases: Results and Lessons Learned
Pp: 191-213
Author(s): Valeria Graceffa*
DOI: 10.2174/1566523221666210728141924
Published on: 28 July, 2021
Gene Therapy for Critical Limb Ischemia: Per Aspera ad Astra
Pp: 214-227
Author(s): Vyacheslav Z. Tarantul* and Alexander V. Gavrilenko
DOI: 10.2174/1566523221666210712185742
Published on: 12 July, 2021
Recent Advances in Predicting Protein-lncRNA Interactions Using Machine Learning Methods
Pp: 228-244
Author(s): Han Yu, Zi-Ang Shen, Yuan-Ke Zhou and Pu-Feng Du*
DOI: 10.2174/1566523221666210712190718
Published on: 12 July, 2021
Therapeutic Approaches for the Management of Autoimmune Disorders via Gene Therapy: Prospects, Challenges and Opportunities
Pp: 245-261
Author(s): Rakesh K. Sindhu*, Piyush Madaan, Parteek Chandel, Rokeya Akter, Griddaluri Adilakshmi and Md. Habibur Rahman*
DOI: 10.2174/1566523221666210916113609
Treatment of GM2 Gangliosidosis in Adult Sandhoff Mice Using an Intravenous Self-Complementary Hexosaminidase Vector
Pp: 262-276
Author(s): Karlaina JL. Osmon, Patrick Thompson, Evan Woodley, Subha Karumuthil-Melethil, Cliff Heindel, John G. Keimel, William F. Kaemmerer, Steven J. Gray and Jagdeep S. Walia*
DOI: 10.2174/1566523221666210916153051
Published on: 24 November, 2021
Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage
Pp: 277-289
Author(s): Xianhai Li, Liu Xiang, Yue Lin, Qiang Tang, Fanbo Meng and Wei Chen*
DOI: 10.2174/1566523221666210907162005
Published on: 07 September, 2021